Page 202 - Tata_Chemicals_yearly-reports-2019-20

16. Other equity
` in crore
As at As at
March 31, 2020 March 31, 2019
(Restated)
1 Capital reserve and other reserves from amalgamation 1,522.74 1,522.74
2 Securities premium 1,258.21 1,258.21
3 Capital redemption reserve 0.10 0.10
4 Debenture redemption reserve - 240.00
5 General reserve 1,411.94 1,171.94
6 Retained earnings 5,859.58 5,742.38
7 Equity instruments through other comprehensive income 1,669.93 2,174.78
Total other equity 11,722.50 12,110.15

The movement in other equity
` in crore
Year ended Year ended
March 31, 2020 March 31, 2019
(Restated)
16.1 Capital reserve and other reserves from amalgamation
Balance at the beginning of the year 1,522.74 21.11
Changes on account of merger (note 36) - 1,501.63
Balance at the end of the year 1,522.74 1,522.74
16.2 Securities premium
Balance at the beginning of the year 1,258.21 1,258.21
Balance at the end of the year 1,258.21 1,258.21
Footnote:
Securities premium is used to record the premium on issue of shares. The reserve is eligible for utilisation in accordance with the
provisions of the 2013 Act.
16.3 Capital redemption reserve
Balance at the beginning of the year 0.10 0.10
Balance at the end of the year 0.10 0.10
16.4 Debenture redemption reserve
Balance at the beginning of the year 240.00 240.00
Transferred to General reseve (240.00) -
Balance at the end of the year - 240.00
Footnote:
The Company is required to create a debenture redemption reserve out of the profits which is available for the purpose of
redemption of debentures, which has been redeemed during the year.
16.5 General reserve
Balance at the beginning of the year 1,171.94 1,171.94
Transferred from Debenture redemption reserve 240.00 -
Balance at the end of the year 1,411.94 1,171.94
Footnote:
The general reserve represents amounts appropriated out of retained earnings based on the provisions of the Act prior to its amendment.

200 I INTEGRATED ANNuAL REPORT 2019-20